Skip to content

Dossier · EPAM · Dormant

EPAM · EPAM SYSTEMS, INC. · Stock research

Last analysed ·

Current thesis

AI-native revenue is compounding ($160M in Q2, >11% of total) but the task-based book is running off faster — FY26 organic constant-currency growth was cut to 2.0%–3.0% on 2026-08-06, Q3 guided to ~1.7% YoY, and the stock closed $97.43, 56% under its 52-week high. The compounder narrative is broken and nothing resolves before the ~November Q3 print.

Invalidation trigger

A weekly close below $92 breaks the post-guidance-cut shelf and confirms the de-rating leg is still running; secondarily, a Q3 report around 2026-11-05 guiding Q4 organic constant-currency growth below zero would end any stabilization case.

Thesis status

Open commitment scored if the trigger above fires How this is scored →

Latest analysis and events for EPAM —

As of 2026-08-08, orbyd's latest analysis for EPAM SYSTEMS, INC. (EPAM): AI-native revenue is compounding ($160M in Q2, >11% of total) but the task-based book is running off faster — FY26 organic constant-currency growth was cut to 2.0%–3.0% on 2026-08-06, Q3 guided to ~1.7% YoY, and the stock closed $97.43, 56% under its 52-week high. The compounder narrative is broken and nothing resolves before the ~November Q3 print.

Invalidation trigger: A weekly close below $92 breaks the post-guidance-cut shelf and confirms the de-rating leg is still running; secondarily, a Q3 report around 2026-11-05 guiding Q4 organic constant-currency growth below zero would end any stabilization case.

Current Thesis

The leg an investor would have been buying here — EPAM as a secular digital-engineering compounder that converts AI into a bigger book — was repriced on 2026-08-06. Q2 revenue of $1.415B (+4.5% YoY, +3.4% organic constant currency) and non-GAAP EPS of $3.38 both cleared consensus, and the company still cut full-year revenue guidance to $5.632B–$5.686B from $5.675B–$5.813B, taking organic constant-currency growth to 2.0%–3.0%. Q3 was guided to $1.410B–$1.425B against a $1.445B consensus — about 1.7% YoY at the midpoint. CEO Fejes attributed it to clients moving budget out of task-based work faster than AI-led replacement work ramps, which he described on the call as "creating a growth gap." That is the company itself describing structural substitution rather than a macro pause.

Life-cycle: DEAD. The dating is specific — the 2026-08-06 guide cut, William Blair's downgrade to Market Perform the same day, and a 2026-08-07 close of $97.43, 56.0% below the $221.4 52-week high. A replacement narrative exists inside the numbers (AI-native revenue of $160M in Q2, more than 11% of total, a sixth consecutive quarter of double-digit sequential growth, tracked by management against roughly a $600M annual figure), but management put the meaningful revenue contribution from large AI-driven deals in early 2027. There is no dated proof point between now and the Q3 print.

Bullish and bearish views on EPAM SYSTEMS, INC.

The model's bull view on EPAM SYSTEMS, INC. (EPAM), in brief: AI-native revenue reached $160M in Q2 2026 — over 11% of total revenue and a sixth straight quarter of double-digit sequential growth (Q2 call, 2026-08-06). The bear view: Full-year revenue guidance cut on 2026-08-06 to $5.632B–$5.686B (3.2%–4.2% growth) from $5.675B–$5.813B, with organic constant-currency growth of 2.0%–3.0%. Both cases follow in full.

Bull Case

  • AI-native revenue reached $160M in Q2 2026 — over 11% of total revenue and a sixth straight quarter of double-digit sequential growth (Q2 call, 2026-08-06). Management holds the roughly $600M annual trajectory despite cutting the top line.
  • Financial Services grew 11.5% YoY and Life Sciences & Healthcare 8% YoY in Q2 2026 (Q2 call, 2026-08-06) — where budgets exist, the AI-led modernization work is being bought.
  • The margin line did not break: non-GAAP income from operations was 16.4% of revenue, GAAP 10.8%, with non-GAAP diluted EPS of $3.38, up 22.0% YoY, against a $3.14 estimate (2026-08-06 release).
  • FY2026 non-GAAP EPS guidance was narrowed with the low end lifted — $12.98–$13.28 to $13.08–$13.24 against a $13.04 consensus — while revenue came down. Mix is moving toward higher-value work even as volume shrinks.
  • Balance sheet funds the transition internally: $789.4M cash, $85M of repurchases in Q2 and $409M year-to-date (2026-08-06 release). The company has been buying its own stock through the de-rating.
  • EPAM joined the OpenAI Partner Network as an Advanced Partner on 2026-07-28 — a credential and distribution datapoint, with no disclosed revenue attached.
  • On the published arithmetic: a $97.43 close against a guided FY2026 non-GAAP diluted EPS range of $13.08–$13.24 is roughly 7x that measure.

Bear Case

  • Full-year revenue guidance cut on 2026-08-06 to $5.632B–$5.686B (3.2%–4.2% growth) from $5.675B–$5.813B, with organic constant-currency growth of 2.0%–3.0%.
  • Q3 2026 guided to $1.410B–$1.425B versus $1.445B consensus — approximately 1.7% YoY at the midpoint, and organic constant currency of about 1.8%. The trajectory points at flat, not at a trough already passed.
  • Software & Hi-Tech revenue fell 1.3% YoY in Q2 2026 (Q2 call, 2026-08-06) on ramp-downs in non-AI services. The most AI-literate client cohort is cutting first, which is what a substitution thesis predicts.
  • Headcount ended Q2 at 62,850 with 56,650 delivery professionals, up 1.5% YoY, against 4.5% revenue growth. If billable-hour work is what agentic delivery compresses, this is the line under pressure.
  • CFO Peterson flagged client vendor-consolidation exercises where customers expect economic advantage — pricing pressure sits alongside the volume problem.
  • Sell-side marked down in one window: William Blair to Market Perform (2026-08-06); PT cuts to $120 from JP Morgan and TD Cowen, $110 from Truist and $146 from Susquehanna (2026-08-07), $120 from Needham (2026-08-06), $100 from Morgan Stanley (2026-08-04) and $100 from Citigroup (2026-07-27).
  • The re-acceleration is dated to early 2027 by management, which declined specific 2027 guidance. Two prints separate the story from its evidence.

Setup & Price Structure

  • Basis close $97.43 on 2026-08-07, 56.0% below the $221.4 52-week high, with a three-month return of -1.8%. Inference, not measurement: a roughly flat quarter that ends 56% below the high implies the tape had recovered ground into the print and the guide cut took it back.
  • No base is visible. One or two sessions of post-gap price is not a shelf, and there is no company-scheduled event to build one against before the Q3 report.
  • A 14-day RSI of 56.8 on the same 2026-08-07 basis is hard to square with a fresh guidance gap; the momentum reading looks like it lags the move and should not be read as strength.
  • Positioning observables, stated as observables: eight sell-side revisions in the 30 days to 2026-08-07, all downward, plus one rating downgrade. Post-cut targets still cluster at $110–$120 with a $100 floor and a $146 high — every published target sits above the $97.43 close, so the analyst complex has not marked to the tape. No earnings date falls inside the next 30 days. No insider transaction filings appear in the recent window. The company repurchased $409M year-to-date rather than issuing into strength.
  • What is absent matters: this is not a retail-clustered name. The coverage density is institutional downgrade flow, which typically produces grinding supply rather than a sharp squeeze.

Catalyst Calendar (next 30 days)

  • None scheduled. As of 2026-08-07, no company-dated event falls inside the window to ~2026-09-07. Flow in that period is sector read-across and residual estimate revisions.
  • ~2026-11-05 (est.) — Q3 2026 results. Tests whether the ~1.7% guided YoY midpoint is the trough, whether AI-native revenue holds the sequential streak, and whether Financial Services' 11.5% growth rate persists.
  • ~2027-02-12 (est.) — Q4/FY2026 results and initial FY2027 guidance. This is where management's "significant revenue contribution from large AI-driven deals beginning in early 2027" either appears as a number or does not.

What Would Change Our Mind

The question is arithmetic: whether the AI-native line ($160M in Q2, over 11% of revenue) grows faster in dollars than the task-based book runs off. Everything else is commentary on that ratio.

Confirming the bear read: a Q4 guide at the November print implying a YoY revenue decline, or organic constant-currency growth below zero; Financial Services decelerating out of double digits; non-GAAP operating margin falling below the 16.4% Q2 level while headcount is flat. On price, a weekly close below $92 breaks the post-guidance-cut shelf and says the de-rating leg is still running.

Flipping constructive would take more than a bounce: AI-native revenue clearing the roughly $600M annual pace with management quantifying an FY2027 contribution, plus a weekly close back above the $110–$120 target cluster to show the tape agrees. Absent both, this is a broken structure with a story dated to 2027, and the case for a fresh entry at $97.43 is weak.

Correlation Notes

  • EPAM sits in the IT-services and digital-engineering complex — Globant, Cognizant, Infosys, Wipro and Accenture are the read-across set. The mechanism is shared: genAI capability that bids up the model and compute layer is the same capability that compresses billable engineering hours downstream. Note the sign: this name can fall on the news that lifts AI infrastructure.
  • Within the group, Globant is the tightest comparison by revenue mix and client profile; Accenture's quarterly bookings commentary tends to set the sector's tone. No dated cross-sectional correlation data is presented here, so treat the peer linkage as a mechanism, not a measured beta.
  • Reported growth ran above organic constant currency in Q2 2026 (4.5% versus 3.4%), so a stronger dollar mechanically pressures the reported line independent of demand.
  • Client concentration by vertical creates its own factor exposure: with Financial Services the fastest-growing vertical at 11.5% YoY, bank and insurer technology budgets are now a larger share of the growth story than software and hi-tech, which declined 1.3% YoY.

Notes

  • EPAM reports on a calendar fiscal year; as of 2026-08-07 no Q3 2026 earnings date had been scheduled.
  • GAAP and non-GAAP guidance diverge widely (FY26: $8.22–$8.38 vs $13.08–$13.24 diluted EPS) — check which basis a headline uses.
  • No dividend. Capital return runs entirely through repurchases: $85M in Q2 2026, $409M year-to-date.
  • Reported revenue growth exceeded organic constant-currency growth in Q2 2026 (4.5% vs 3.4%), so FX flatters the headline line.

Related · shared themes

HPE

Hewlett Packard Enterprise Company

Five straight up sessions took HPE to a $53.22 close on 2026-08-07 with the 2026-08-04 gap floor at $50.24 still untested; Trefis put the five-day move at +19.8% against +5.6% for the S&P 500, so this leg is no longer pure sector beta. Forward P/E 13.79 versus 49.66 trailing. The still-unconfirmed ~2026-09-02 Q3 print against the $11.5–12.1B / $0.88–0.93 guide is the binary.

MEDIUM

HUM

Humana Inc.

Post-print floor held: the 2026-08-05 undercut to $353.69 closed green on CVS's Aetna guide raise, and 2026-08-07 closed $385.00 (+4.84%), back above the 50-day of $374.23 and the highest close since 07-28. Morgan Stanley's 08-05 upgrade retired the $249 bear target, but the ≥3% 2028 MA margin claim stays unquantified for 2027 and no company-dated financial event is confirmed inside 30 days.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

SIMO

Silicon Motion Technology Corporation

Controller-mix decoupling got its first hard datapoint on 2026-08-06 — SIMO +8.42% to $267.43 while Western Digital fell 16% and SanDisk 11% on beat-but-guide-light prints — then gave most of it back on 08-07 (-4.23% to $256.12, $18.87 off the high, thinnest volume of the run). Six sessions after a beat-and-raise the ADS sits $1.02 above the 07-30 reaction close; the 50-day at $286.82 is unreclaimed.

MEDIUM